Universal Time: 15:27  |  Local Time: 15:27 (0h GMT)
Select your timezone:
Reset

Sun Sep 13

00:00 Symposium: Lessons Learned about COVID-19
105.4 Immunogenetics (HLA and ABO)
Lori Jeanne West, Canada
105.6 Global Impact of COVID-19 on Transplantation
Alexandre Loupy, France
105.1 Virology, Epidemiology and Clinical Course
Olivia S. Kates, United States
105.2 Organ Specific Involvement of COVID-19
Aneesha Anand Shetty, United States
105.3 Diagnostics:  PCR, Antigen Detection and Serology 
Robin Patel, United States
105.5 Therapeutics & Vaccines
Michael G. Ison, United States
00:00 Symposium: Transplanting in the Era of COVID-19
110.2 When a Recipient with COVID-19 Can Proceed to Transplant
Paolo Antonio Grossi, Italy
110.1 Donor Screening and the Risk of Virus Transmission
Thomas D. Mone, United States
110.4 Transplantation in the Hot Zone
Jean C. Emond, United States
110.3 Lung Transplantation for COVID-19
Jingyu Chen, People's Republic of China
110.5 Transplantation and Ethical Issues in the COVID Era: Doing the right thing depends on location, resources and disease burden
Peter G. Stock, United States
23:30 - 00:15 Oral Abstracts Session: Living Donor Liver Transplantation
212.1 Survival benefits of living donor liver transplant for hepatorenal syndrome candidates on waitlist
Tiffany Cho-Lam Wong, Hong Kong
212.2 Outcomes of robotic living donor right hepatectomy from 52 consecutive cases: Comparison with open and laparoscopy-assisted donor hepatectomy
Seoung Yoon Rho, Korea
212.3 Robotic living donor right hepatectomy: A current standardized procedure
Hyeo Seong Hwang, Korea
212.4 Demarcating the exact midplane of the liver using indocyanine green near-infrared fluorescence imaging during laparoscopic donor hepatectomy
Jeesun Kim, Korea

Mon Sep 14

08:15 - 10:00 State-of-the-Art Session: Evidence-Based Teaching
260.1 Cognitive sciences based design of engaging training programs for transplant professionals
Margaret Hay, Australia
260.2 Ethical principles for transplant professionals: How do we teach that?
Dominique Martin, Australia
260.3 Future transplant surgeons: How do we train them?
Abul Siddiky, United Kingdom
08:15 - 10:00 State-of-the-Art Session: Banff 2019 Update for Allograft Rejection
262.1 Liver (morphology)
Andrew Clouston, Australia
262.4 Kidney (molecular)
Carmen Lefaucheur, France
262.3 Kidney (morphology)
Hyeon Joo Jeong, Korea
262.2 Liver (molecular phenotyping)
Alberto Sanchez-Fueyo, United Kingdom
15:15 - 17:00 State-of-the-Art Session: Social Media for Scientists
291.3 Impact of social media on research dissemination
Carla C. Baan, Netherlands
291.1 Introduction and creating networks
Frank JMF Dor, United Kingdom
291.2 Healthcare and patient education
Macey L. Henderson, United States
22:00 - 23:30 Workshop Session: Cutting-Edge Issues in Peri-Transplant Management
301.3 Management of pre-DSA and LCM positive
Jacqueline O'Leary, United States
301.2 Management of ABO incompatibility
Toru Ikegami, Japan
301.1 Management of hepatitis C virus
Paul Kwo, United States

Tue Sep 15

08:15 - 10:00 State-of-the-Art Session: The Future is Now… Immune Regulation in Transplantation
360.1 The Regulation of Immune Tolerance by FOXP3 - basic
Ling Lu, People's Republic of China
360.2 Intragraft immune regulation protects transplants under sub-therapeutic immunosuppression
Paloma Riquelme, Germany
James Alexander Hutchinson, Germany
360.3 Clinical experience of Treg therapy
Fadi Issa, United Kingdom
08:15 - 10:00 Workshop Session: TTS-WTGF Joint Session: How to harness exercise post – transplantation (Impact) and how to measure patient reported outcomes in the Covid-19 Era
363.1 Introduction and Welcome
Chris Thomas, Australia
363.3 Refit for life (online rehabilitation program) as a way of delivering increased Qalys and outcomes
Liz Schick, Switzerland
363.2 Safety of various sports post transplant to dispel the myth of unacceptable risk in the context of Covid
Paul Harden, United Kingdom
363.6 Billion Steps Challenge 2: The Sequel – Using online exercise challenges to engage activity in transplant recipients
Ka-Foon Chau, Hong Kong
363.4 Potential impact of exercise and sport on patient outcomes
Gareth Wiltshire, United Kingdom
363.5 Results of survey – Organ Transplant recipients health outcomes
Zachary S. Brooks PhD, United States
08:15 - 10:00 Workshop Session: TTS-ISN Joint Session: Integrated Care of Patients with Kidney Failure
364.1 Why does the world need an integrated plan for ESKD care?
David Harris, Australia
364.2 What is realistic in setting and achieving quality standards in dialysis
Simon J. Davies, United Kingdom
364.3 Conservative kidney care - its time has come
Edwina Brown, United Kingdom
364.4 Challenges in setting up a transplant program in resource-limited settings
Ifeoma I Ulasi, Nigeria
13:00 - 14:45 Workshop Session: Global Strategies for Facilitating Ethical Practices in Organ Transplantation
377.4 Developing programs in resource constrained areas – Vietnam
Richard Allen, Australia
377.3 Organ transplantation for refugees: The Latin American case
Alejandro Niño Murcia, Colombia
377.5 Combating paid donation in India
Vivek Kute, India
377.8 Strategies for increasing deceased donation in Iran
Seyed Ali Malek Hosseini, Iran (Islamic Republic of)
377.6 Combating paid donation in the Philippines
Benita Padilla, Philippines
377.1 Resident minorities Access to organ donation and transplantation – Middle-East
Riadh Fadhil, Qatar
377.2 Non-resident access to transplantation and impact on local lists – Europe
Beatriz Domínguez-Gil, Spain
377.7 Transplanting the undocumented in the USA
Peter G. Stock, United States
14:30 - 15:15 Oral Abstracts Session: Immune Regulation and Tolerance I
381.4 Single cell immune profiling of human intestinal allografts reveals heterogeneity and alloreactivity of recipient resident memory T cells in association with graft outcomes
Jianing Fu, United States
381.1 Treg use the PD-1-PD-L1 axis for lymphatic transendothelial migration
Wenji Piao, United States
381.2 Donor liver plasmacytoid dendritic cells promote effector T cell exhaustion and augment Treg responses in mouse spontaneous liver transplant tolerance
Ryosuke Nakano, United States
381.3 Lymph node stromal laminin alpha 5 regulates adaptive immunity
Lushen Li, United States

Wed Sep 16

00:15 - 02:00 State-of-the-Art Session: Preventable Infections - An Ounce of Prevention...
420.2 Screening and decolonization of MDROs pre-transplant: Is there a role?
Stephanie Pouch, United States
420.1 Respiratory viruses - Impact on our recipients
Michael G. Ison, United States
420.3 Keeping the fungi out of the transplant ward
Monica Slavin, Australia
00:15 - 02:00 Workshop Session: Upcoming Issues in the Diagnosis of Transplant Rejection
423.3 Dilemmas in renal allograft biopsy diagnosis
Brian J Nankivell, Australia
423.2 Gene expression in transplant tissue and body fluid
Michael Mengel, Canada
423.1 Digital pathology and machine learning in renal transplant pathology
Alton "Brad" Farris, United States
06:00 - 07:30 Workshop Session: Global Ethical Issues
441.2 Organ donation after euthanasia
Diethard Monbaliu, Belgium
441.3 Ethical issues in xenotransplantation and stem cell trials
Ian D. Dittmer, New Zealand
441.4 Ethical issues involved with informed consent for living donors
Guia Crisostomo-Tan, Philippines
441.1 Ethics and the social network in transplantation
Elmi Muller, South Africa
07:30 - 08:15 Oral Abstracts Session: Immune Regulation and Tolerance II
451.3 PD-L1 / PD-1 interactions are critical for tolerance induction in primed skin graft recipients following liver-directed MHC class I gene transfer
Mario L Leong, Australia
451.2 Identification and isolation of human HLADR+ CD27+ Treg as xeno-antigen Treg subset for xenotransplantation
Xiaoqian Ma, People's Republic of China
451.1 Transient antibody targeting of CD45RC to prevent the development of acute graft versus host diseases
Carole Guillonneau, France
451.4 CTLA-4-Ig prolongs graft survival specifically in young but not in old recipients
Jasper Iske, Germany
07:30 - 08:15 Oral Abstracts Session: Education and Vascularized Composite Allograft
453.4 Organ donation innovative strategies for Southeast Asia: ODISSeA
María Paula Gómez, Spain
453.5 (P-5.02 in Journal) EUDONORGAN – Innovative European project training and social awareness for increasing organ donation
Marti Manyalich Vidal, Spain
453.2 Adipose derived mesenchymal stem cell delivered endothelial protection during graft vasculopathy during vascularized composite tissue allotransplantation
Pranitha Kamat, Switzerland
453.3 Desensitization using costimulatory blockade and bortezomib in reconstructive transplantation
Byoung Chol Oh, United States
08:15 - 10:00 State-of-the-Art Session: Minimally Invasive Surgery for LDLT
461.1 Small incision donor hepatectomy
Toru Ikegami, Japan
461.2 Pure laparoscopic donor hepatectomy
Kyung-Suk Suh, Korea
461.3 Robotic donor hepatectomy
Dieter Clemens Broering, Saudi Arabia
14:30 - 15:15 Oral Abstracts Session: Kidney Transplantation: Desensitization and other complications
480.4 Rapamycin prevents interstitial fibrosis through decreasing peritubular capillary (PTC) VEGF expression and angiogenesis while inducing glomerular sclerosis and proteinuria through decreasing glomerular VEGF expression
Binnaz Handan Ozdemir, Turkey
480.3 CD8+ T cell senescence is a distinct immunological state that identifies long-term renal transplant recipients at increased risk of future malignancy
Matt J Bottomley DPhil, United Kingdom
480.1 Clazakizumab® (Anti-IL-6) for desensitization of highly-HLA sensitized patients awaiting kidney transplant (NCT03380962)
Ashley Vo, United States
480.2 Clazakizumab (anti-IL-6) induces FoxP3+ Tregs in highly HLA sensitized patients receiving HLAi kidney transplantation (NCT03380962)
Stanley Jordan, United States
14:30 - 15:15 Oral Abstracts Session: Education Abstract Session
482.4 The efficiency of educational courses for increasing organ donation rates; The IrOSS experience
Marzieh Latifi, Iran (Islamic Republic of)
482.1 Analysis of the effects of coordinator mental health management program
Kyungsook Jang, Korea
482.2 i-DTI: An electronic consultancy platform between professionals in the field of organ donation and transplantation
Estephan Arredondo, Spain
482.3 Save lives! Say yes! Increasing donor designation rates through targeted, demographic specific public education: Turning opportunity into outcomes
Betsy Edwards, United States
14:30 - 15:15 Oral Abstracts Session: Ethical Issues
483.4 Ethical issues of the Global Kidney Exchange Program as viewed from a low-to-middle country’s perspective
Maryn Reyneke-de Kock, Belgium
483.2 The effect of COVID-19 on the working and psychological status of medical staffs in organ donation and transplantation
Hui Tian, People's Republic of China
483.1 Travel for transplantation: Impact on liver transplant candidates and recipients in the United States
Hillary J Braun, United States
15:15 - 17:00 State-of-the-Art Session: Declaration of Istanbul Issues
493.1 Global organ trafficking registry
Patrick Coates, Australia
493.2 What is wrong with de Global Kidney Exchange Program
Alexander M. Capron, United States
493.3 The MAIN obstacle to increase organ transplantation in Africa
Elmi Muller, South Africa
493.4 The MAIN obstacle to increase organ transplantation in the Middle-East
Refaat Kamel, Egypt
493.5 The MAIN obstacle to increase organ transplantation in Latin America
Maria A. Matamoros, Costa Rica
493.6 The MAIN obstacle to increase organ transplantation in Asia
Sanjay Nagral, India
493.7 The MAIN obstacle to increase organ transplantation in Europe
Axel Rahmel, Germany
493.8 Final Remarks and Panel Discussions
Alejandro Niño Murcia, Colombia

E-Posters

Poster Session: Education
P-5.11 Influence of promotional strategies for the donation and transplantation of organs, fabrics and cells in the petroleum hospital of Bolivia, 2020
Tatiana Rosario Cruz Jr., Bolivia
P-5.08 Effectiveness of a structured sub-maximal stress test for screening asymptomatic post-organ transplant recipients before safe return to sports competition
Ka-Foon Chau, Hong Kong
P-5.12 Measuring the relationship between subjective health literacy and access to kidney transplantation among chronic renal patients in Eastern Hungary
Anita Barth, Hungary
P-5.14 Knowledge and attitude towards organ donation and transplantation among a sample of Iraqis in the city of Baghdad
Ala Ali, Iraq
P-5.03 TPM training program in tissue banking & advanced therapies: A 15-year experience
Chloë Ballesté, Spain
P-5.04 Survey on leadership, management, quality and innovation in organ procurement for the self-sufficiency in organ donation of the one belt & one road area
Marti Manyalich Vidal, Spain
P-5.07 KeTLOD Bridge : Scholarships for facilitating the transfer of knowledge and leadership in organ donation and transplantation from Europe to China (2018-2019)
Chloë Ballesté, Spain
P-5.15 Dance as a medium to educate and make comprehensible the biology of allotransplant rejection
Pranitha Kamat, Switzerland
P-5.06 Transformative learning in pharmacy education: A paradigm shift for training transplant pharmacists
Sayamon Sukkha, Thailand
P-5.01 Eliminating patient controlled analgesia reduces opioid use in renal transplant recipients
Marisa E Schwab, United States

WebApp Sponsor

© 2020 TTS 2020